Breakthrough: New Drug Candidates Show Promise in Treating Addiction and Depression
Scientists have developed two new drug candidates inspired by the traditional African psychedelic plant medicine ibogaine, which have the potential to treat addiction and depression. These compounds target the serotonin transporter and mimic ibogaine's desirable effects without its dangerous side effects. Initial testing in mice has shown promising results, and further research is underway to explore their therapeutic potential. The new molecules are more powerful than SSRI antidepressants and could offer a safer and more effective treatment option for patients suffering from addiction and depression.